Abstract Studies on endocrine disruption in Australia have mainly focused on wastewater effluents. Limited knowledge exists regarding the relative contribution of different potential sources of endocrine active compounds (EACs) to the aquatic environment (e.g., pesticide run-off, animal farming operations, urban stormwater, industrial inputs). In this study, 73 river sites across mainland Australia were sampled quarterly for 1 year. Concentrations of 14 known EACs including natural and synthetic hormones and industrial compounds Sci Pollut Res (2014) 21:12951-12967 DOI 10.1007 were quantified by chemical analysis. EACs were detected in 88 % of samples (250 of 285) with limits of quantification (LOQ) ranging from 0.05 to 20 ng/l. Bisphenol A (BPA; LOQ =20 ng/l) was the most frequently detected EAC (66 %) and its predicted no-effect concentration (PNEC) was exceeded 24 times. The most common hormone was estrone, detected in 28 % of samples (LOQ=1 ng/l), and the PNEC was also exceeded 24 times. 17α-Ethinylestradiol (LOQ=0.05 ng/l) was detected in 10 % of samples at concentrations ranging
Introduction
Since the early 1980s, there has been increasing evidence that endocrine active compounds (EACs) negatively affect fish reproduction and pose a risk to ecological and human health (McLachlan et al. 1984 ; WHO/UNEP 2013). The first evidence of endocrine disruption in the aquatic environment was reported in the 1980s, when masculinized female mosquitofish (Gambusia holbrooki) were identified up to 6.5 km downstream of a pulp mill effluent discharge (Howell et al. 1980) . Additional research has since demonstrated that endocrine disruption in aquatic environments is a widespread problem (Campbell et al. 2006; Jobling et al. 1998; Sumpter 2005 ; WHO/UNEP 2013) and often associated with chemicals present in municipal and industrial wastewater discharges.
The first evidence of endocrine disruption in Australian rivers was reported in 1999 when male mosquitofish, captured downstream of a wastewater treatment plant (WWTP) in the Greater Sydney area, were shown to exhibit significantly reduced gonopodium length (a common biomarker of exposure to estrogenic and/or antiandrogenic EACs in mosquitofish) compared with male mosquitofish captured at a reference site (Batty and Lim 1999) . Follow-up laboratory studies demonstrated significantly decreased gonopodium length and reduced sexual activity after exposure to estrogenic EACs Lim 2002, 2005) . Mosquitofish have since been used as bioindicators of EAC exposure in other Australian studies, with varying results. Some studies have reported no significant estrogenic effects in male mosquitofish exposed to domestic secondary treated wastewater but a possible minor androgenic effect resulting in slight elongation of female anal fins (Leusch et al. 2006a) , while other studies have found significant reduction in gonopodium length consistent with estrogenic exposure in a lake impacted by urban and agricultural activities (Game et al. 2006) .
Endocrine disruption research in Australia has largely focused on WWTP effluent discharges using chemical and, more recently, in vitro bioassay methods. As with the mosquitofish studies, those studies have yielded inconsistent results. Depending on the level of treatment, estrogenic EACs are sometimes detected in WWTP effluent at low ng/l (ppt) concentrations comparable to those found in other developed countries (Table 1) . The handful of studies that have analyzed river water samples have also detected low concentrations of estrogenic EACs and/or estrogenic activity (Chinathamby et al. 2013; Leusch et al. 2010; Tan et al. 2007; Williams et al. 2007; Ying et al. 2009; Ying et al. 2008 ; Table 1) .
Globally, most studies to date have measured in vitro estrogenic activity and, occasionally, androgenic activity, but almost none have measured anti-estrogenic, antiandrogenic, or progestagenic/anti-progestagenic activity (GWRC 2012; Rostowski et al. 2011; Urbatzka et al. 2007) . There is significant cross-talk between endocrine axes, and a recent study indicated that anti-androgens may be as important as estrogens to endocrine disruption in animals inhabiting the aquatic environment (Jobling et al. 2009 ). The level of non-estrogenic endocrine activity in Australian rivers is currently unknown.
To date, the Australian literature on endocrine disruption in the aquatic environment associated with WWTP effluent discharges emphasizes the need for more comprehensive studies (Williams et al. 2007 ). In particular, there is a need to understand the contribution of non-point sources, such as industrial and agricultural inputs. A review on agricultural feedlot wastes in Australia ) stressed the need for additional research on dairy shed effluents, which can be a significant source of steroidal input into aquatic environments (Gadd et al. 2010; Matthiessen et al. 2006) . The very few studies in this area suggest that dairy operations may be significant sources of steroid hormones (Table 1) (Williams et al. 2007 ; Game et al. 2006) , and that there may well be non-wastewater sources of EACs in Australian rivers.
This study aimed to (1) assess multiple classes of EACs by measuring the (anti)estrogenic, (anti)androgenic and (anti)progestagenic activity in Australian rivers using in vitro bioassays; (2) quantify by trace chemical analysis EACs such as steroid hormones and industrial compounds, known to be significant contributors to endocrine activity in Australian waters (Tables 1 and 4 , and Leusch et al. 2010 Leusch et al. , 2014a ; and (3) identify possible trends of EAC concentrations across mainland Australia using data obtained in the first two objectives, focusing specifically on agricultural, industrial, residential, and wastewaterreceiving sites. Table 2) . From the shore, two acetone-rinsed 1-l amber glass bottles were submerged approximately 30 cm below the water surface in order to collect the 2-l water sample required. To prevent biodegradation, the pH of each water sample was immediately adjusted to approximately pH 2 by addition of 1.5 ml of concentrated HCl (12 M). Basic water chemistry parameters (dissolved oxygen, electric conductivity, pH, temperature) were recorded prior to pH adjustment. Samples were then packed with frozen ice blocks and sent by overnight courier to the laboratory for solid-phase extraction (SPE). One laboratory blank using deionized water was created and analyzed for each sampling event.
None of the monitored chemicals or bioassay responses were detected in any of the blanks.
Solid-phase extraction
On arrival at the laboratory, the pH of the samples was finely adjusted to 2 using HCl (12 M), stored at 4°C and extracted within 24 h. Samples were vacuum filtered through 2-μm pore size glass fibre filters (47 mm diameter; Millipore, VIC). For a review of estrogenic activity in surface waters and effluents in other countries, see Jarosova et al. (2013) , Kostich et al. (2013) , Loos et al. (2013) , Duong et al. (2010) , and Jobling et al. (2006) LOD limit of detection, EEQ 17β-estradiol equivalents, TMXEQ tamoxifen equivalents, TEQ testosterone equivalents, DHTEQ dihydrotestosterone equivalents, FluEQ flutamide equivalents, LevoEQ Levonorgestrel equivalents; ACT Australia Capital Territory, QLD Queensland, SA South Australia, NSW New South Wales, VIC Victoria, WA Western Australia
Water from each 1-l sample bottle was passed through its own preconditioned SPE cartridge (Waters Oasis HLB SPE cartridges; 500 mg sorbent, 6 ml; Waters, NSW) at 10 ml/min. Conditioning consisted of 10 ml of acetone/hexane (1:1), followed by 10 ml methanol, and finally 10 ml ultrapure water through each cartridge. After passing the full water sample, the SPE cartridges were dried under vacuum at 20 mmHg for 2 h (or until dry). Dried cartridges were wrapped in aluminium foil and stored at 4°C (for up to 2 weeks) until elution. The polar fraction was eluted with 10 ml methanol and the nonpolar fraction was eluted with 10 ml acetone/hexane (1:1). The fractions from replicate cartridges were combined and evaporated under nitrogen until dry and immediately reconstituted in 1 ml methanol for analysis. Reconstituted samples were split into 2× 500 μl aliquots for in vitro and chemical analyses.
Chemical analysis 4-tert-Octylphenol (4-t-OP) and bisphenol A (BPA) surrogates were added to each sample immediately prior to analysis and these compounds were analyzed by liquid chromatographytandem mass spectrometry (LC-MS/MS) based on the method of Vanderford and Snyder (2006) . Transitions can be found in Online Resource 2. Hormones were analyzed A catchment assessment was used to determine the most influential land-use type WWTP wastewater treatment plant by gas chromatrography-tandem mass spectrometry (GC-MS/MS) as described by Trinh et al. (2011) . Standard solutions of all analytes were prepared at 1, 5, 10, 50, 100, 500 and 1,000 ng/ml concentrations. A relative response ratio of analyte/internal standard over a 1-1,000 ng concentration range was generated enabling quantification with correction for losses due to ion suppression. All calibration curves had a correlation coefficient of 0.99 or better. Limits of quantification (LOQs) were defined as the concentration of an analyte giving a signal to noise ratio greater than 10.
Ethinylestradiol analysis by ELISA A commercially available enzyme-linked immunosorbent assay (ELISA) method was modified to improve on the GC-MS/ MS quantification limit for 17α-ethinylestradiol of 1 ng/l. 17α-Ethinylestradiol ELISA kits (originally sourced from Takiwa Chemical Industries in Japan) were purchased from Biosense Laboratories (Norway). In order to decrease the LOQ, standards were first diluted 10× with deionized water, a concentration that still produced a repeatable and concentration-dependent response. Samples were tested twice on different days, and standard curves were generated in duplicate. The LOQ for the full method including sample enrichment by SPE was 0.05 ng/l 17α-ethinylestradiol.
CALUX bioassays
The ERα-, AR-and PR-CALUX bioassays were conducted using previously published methods (Legler et al. 1999; Sonneveld et al. 2005 Sonneveld et al. , 2011 with slight modifications noted in Leusch et al. (2010) . Briefly, human U2-OS cell lines stably transfected with a luciferase reporter gene downstream of an ERα, AR or PR responsive element are exposed to SPE extracts. Active compounds in the extracts bind and activate the nuclear receptors generating luciferase activity, which is measured after addition of luciferin. Luminescence was read with a FLUOstar Omega Spectrometer (BMG Labtech, Germany). A nonlinear regression method is used to analyze the generated concentration-effect curves and express activity in model compound equivalents.
Data analysis and statistics
As is often the case with environmental studies, the dataset was heavily left censored with a large proportion of nondetects. Non-detections from biological activity data were assigned a value of half of the LOQ for calculation of averages and standard error of mean (SEM) for graphical purposes.
Results and discussion

Chemical analysis of EACs
Most samples (88 %) had a detectable concentration of at least one of the 14 EACs monitored; however, on average, only a handful of the 14 EACs monitored were detected in each sample, with 1.3 compounds detected on average in residential samples, 1.2 EACs in samples downstream of WWTP discharges, 1.1 EACs in industrial samples, 1.0 EACs in agricultural and 0.9 EACs in undeveloped samples (the median for all land uses was 1). The maximum number of EACs detected in one sample was four, in a sample collected downstream of a WWTP. Frequencies of detection for each state can be found in Online Resource 3.
Estrone was the most abundant hormone measured in this study (detected in 27 % of samples) with a maximum concentration of 57 ng/l in an industrial sample and a residential sample, both from NSW (Table 3) . Estrone was most frequently detected in residential samples and WWTP samples (32 % of all samples in both land uses), followed by undeveloped (26 %), agricultural (25 %) and industrial samples (14 %). Estrone detection frequencies did not differ greatly among states but the overall detection frequency was higher in the present study (27 %; LOQ=1 ng/l) compared to a US survey (7 %; LOQ=5 ng/l) (Kolpin et al. 2002) . The concentrations of estrone detected in this study were comparable but slightly higher than most of those previously reported in Australian rivers and wastewater (Table 1 ) and other studies (Young et al. 2004 ), but at least half the maximum concentration of 112 ng/l found in a US stream (Kolpin et al. 2002) . A predicted noeffect concentration (PNEC) of 6 ng/l for estrone, was derived by assessing vitellogenin induction in multiple fish species . Out of the 78 samples that had quantifiable estrone, 24 had concentrations at or above the PNEC indicating a potential risk to fish at the corresponding sampling locations.
Thirteen samples contained 17α-ethinylestradiol, the synthetic hormone primarily used in human birth control pills, at concentrations greater than its PNEC of 0.1 ng/l (Young et al. 2004 ; Table 3 ). 17α-Ethinylestradiol concentrations were also lower in the present study, compared to river samples taken downstream of WWTPs in other Australian studies (Ying et al. 2009; Ying et al. 2008 ; Table 1 ). The detection frequency (10 %) was similar to a US surface water study (16 %; LOQ= 5 ng/l) (Kolpin et al. 2002) . Surprisingly, there was no clear relationship between the presence of 17α-ethinylestradiol and land-use category: the 13 samples with quantifiable 17α-ethinylestradiol concentration were evenly distributed among agricultural (four), residential (three), downstream of WWTPs (two), industrial (two) and undeveloped (two) sites. The existence 17α-ethinylestradiol in this wide variety of land-use classes indicates the presence of human wastewater even Of the other estrogenic hormones monitored, 17β-estradiol, estriol and mestranol were not detected above their LOQ (1, 3 and 1 ng/l, respectively), and 17α-estradiol was only detected in one agricultural sample (at 4 ng/l; LOQ=1 ng/l). While no samples in this study contained 17β-estradiol, a US survey reported its presence in 10 % of surface water samples (LOQ= 5 ng/l) (Kolpin et al. 2002) . 17β-Estradiol is frequently detected in Australian wastewater (Table 1) , but it has a comparatively short half-life in river water and is degraded to estrone (Jürgens et al. 2002) , and thus likely contributes to the frequent detection of estrone in our samples.
Androgenic hormones were only occasionally detected. A maximum concentration of 36 ng/l for androstenedione was detected twice (LOQ=5 ng/): once in a SA WWTP sample and once in a WA WWTP sample. Lower concentrations were also detected in three other WWTP samples and one residential sample (Table 3) . Androsterone, DHT, etiocholanolone and testosterone were not detected in any sample (n=285) above their LOQ (1, 16, 6 and 5 ng/l, respectively). The only other Australian study measuring androgenic compounds in river samples did not find androsterone or etiocholanolone (Tan et al. 2007 ; Table 1 ). Androstenedione, androsterone, etiocholanalone and testosterone have been previously detected in Australian WWTP effluents at maximum concentrations of 17, 67, 180 and 2.9 ng/l, respectively (Allinson et al. 2008; Leusch et al. 2014b ; Table 1 ).
The progestin levonorgestrel was not detected in any sample (LOQ=5 ng/l, n=285) and has not been detected in Australian rivers to date (Table 1) , nor was it detected in Spanish rivers (LOQ=5 ng/l) (Kuster et al. 2008) . The lack of detection is likely due to the high LOQ of current analytical methods. Levonorgestrel, together with 17α-ethinylestradiol, is an active ingredient in the birth control pill and so it is surprising that it was not detected in this study. Two possible explanations are that it may be metabolized by the body more completely than 17α-ethinylestradiol, or the chemical and in vitro LOQs (both 5 ng/l) were simply not sensitive enough to detect levonorgestrel at the environmentally relevant concentrations. High blood plasma concentrations (up to 12 ng/ml) have been found in trout exposed to WWTP effluent (Fick et al. 2010 ) and concentrations as low as 0.8 ng/l can cause infertility in fathead minnow (Zeilinger et al. 2009 ). Further investigation using improved method detection limits is warranted considering the occurrence of 17α-ethinylestradiol in several samples.
With a maximum concentration of 4,130 ng/l in a NSW industrial sample and a detection frequency of 65 %, the industrial compound BPA (LOQ=20 ng/l) was the most prevalent EAC detected in the present study. BPA was detected in 76 % of residential samples, 75 % of industrial samples, 66 % of WWTP samples, and 58 % of each agricultural samples and undeveloped samples (but was not detected in laboratory blanks). The concentrations of BPA in the present study were higher than those previously reported for Australia (Table 1) . BPA was detected at a higher frequency in Australian freshwater streams compared to that reported for US streams (65 % vs. 41 %) and had a higher maximum concentration (4,130 ng/l vs. 1,900 ng/l) (LOQ=90 ng/l) (Kolpin et al. 2002) . BPA concentrations were also considerably higher than those reported at a WWTP impacted canal in Greece (380 ng/l; LOQ=7 ng/l) (Arditsoglou and Voutsa 2008) or surface water in Germany (maximum BPA concentration of 410 ng/l; LOQ=0.1 ng/l) (Fromme et al. 2002) . Canada has adopted a PNEC of 175 ng/l for BPA (Environment and Health 2008), derived using a 103-day exposure and then measuring brown trout semen quality and delayed ovulation. In our study, 24 samples had concentrations above 175 ng/l. As such, BPA could negatively affect fish reproduction at the corresponding sample locations.
4-t-OP was detected in 21 samples with a maximum concentration of 81 ng/l. It was found frequently in residential samples (20 %). A PNEC of 330 ng/l, established by measuring chronic activity in Oryzias latipes (Japanese medaka) (Ministry of the Environment in Japan 2009), indicates that concentrations of 4-t-OP reported here are unlikely to be of ecological concern.
With quarterly sampling, only limited conclusions can be drawn on temporal trends: 4-t-OP was detected 15 times in the spring sampling event; however, it was only detected three times in the other three seasons. BPA was prevalent in the autumn, winter, and spring, with 47 %, 58 % and 71 % detection frequencies, respectively, but it was only detected in 1 % of samples from the summer sampling event. No other temporal trends between sampling events were identified for any of the other monitored chemicals (data not shown).
Estrogenic and anti-estrogenic activities
Nineteen percent of all samples (53) had quantifiable estrogenic activity (>0.1 ng/l EEQ; Fig. 2, top) , with 2 % of samples (seven) above 1 ng/l EEQ. The detection frequency was highest in residential samples (27 %), followed by industrial (25 %), agricultural (20 %), WWTP (14 %) and undeveloped samples (6 %). The highest estrogenic activity was detected downstream of a WWTP discharge, at 6.5 ng/l EEQ. Anti-estrogenic activity was not detected in any water samples using the ERα-CALUX assay (LOQ=5 μg/l tamoxifen equivalent, TMXEQ).
Our estrogenic results are comparable to those previously reported in Australia (Table 1 ) and other industrialized countries. For example, a Dutch study reported 0.2-0.5 ng/l EEQ in surface waters using the ERα-CALUX (van der Linden et al. 2008) , while a US study calculated a maximum activity of 1.5 ng/l EEQ based on a pharmaceutical assessment and transport evaluation (PhATE) . These concentrations are much lower than those reported in a study comparing eight Asian countries, with predicted estrogenic activities of 4-46 ng/l EEQ in surface waters based on chemical concentrations (Duong et al. 2010) .
There is still some uncertainty as to what constitutes an unsafe level of estrogenic activity in river water. A PNEC for 17β-estradiol of 1 ng/l (Young et al. 2004) translates into 1 ng/ l EEQ in the ERα-CALUX. In our study, seven samples exceeded 1 ng/l EEQ (Fig. 2, top) , indicating potential estrogenic effects in exposed aquatic organisms at those sites. None of the samples from the same site exceeded 1 ng/l in subsequent sampling events, which suggests that high estrogenicity was not a persistent condition. However, lowlevel estrogenicity was detected more than once at each of the seven sites. With one exception, the high estrogenic results occurred in the spring (Nov 2011) and summer (Feb 2012) samples. There was no clear land-use activity associated with the seven high estrogenic results, with three residential, two agricultural, one industrial and one WWTP samples above 1 ng/l EEQ. These results emphasize the need to better characterise non-point sources and not merely focus on sites downstream of WWTPs. Jarosova et al. (2013) derived bioassay-based short-and long-term safe EEQs (EEQ-SSE) that, when exceeded, indicate a potential in vivo risk. For the ER-CALUX bioassay, the proposed EEQ-SSEs were 0.2-0.4 ng/l EEQ for long-term Error bars represent the standard error of the mean, with nondetects assigned a value of half the limit of quantification. Points represent values above the mean. LOQ limit of quantification, DL detection limit and 0.6-2 ng/l EEQ for short-term exposures. All 53 estrogenic samples in this study exceeded the most conservative long-term EEQ-SSE (0.2 ng/l EEQ). In more detail, 18 sites had measurable estrogenicity in only one sample (0.3-0.9 ng/l EEQ), while nine sites had two positive samples (0.3-6.5 ng/l EEQ). The lowest short-term EEQ-SSE (0.6 ng/l EEQ) was exceeded on 19 occasions at 16 sites compared to the highest short-term EEQ-SSE (2 ng/l EEQ), which resulted in only one exceedance. Three sites had estrogenicity in three out of four samples (0.2-1.2 ng/l EEQ) and two sites had activity in all four samples (0.3-2.6 ng/l EEQ). All of the above sites exceeded the long-term EEQ-SSE at least once, regardless of what value was applied. In total, 25 samples were above 0.6 ng/l EEQ and two were above 2 ng/l EEQ.
Most of the estrogenic samples in this study had activities between 0.1 and 1 ng/l EEQ. This level of estrogenic activity presents a low risk when compared to the PNEC for 17β-estradiol, but special consideration needs to be given to 17α-ethinylestradiol. Indeed, while 17α-ethinylestradiol is almost equipotent to 17β-estradiol in vitro (Legler et al. 2002) , it is 10× more potent in vivo and subsequently has a PNEC of 0.1 ng/l (Young et al. 2004; Caldwell et al. 2012 ). As such, a sample with an EEQ as low as 0.1 ng/l may still be of environmental concern if all that activity is caused by 17α-ethinylestradiol. For this reason, all estrogenic samples above 0.1 ng/l EEQ were re-analyzed using a more sensitive ELISA method. More than half of all estrogenic samples (28 out of 53) had quantifiable 17α-ethinylestradiol concentrations (>0.05 ng/l), confirming that estrogenic activity in river water samples was often associated with its presence. Almost a quarter (13) of all estrogenic samples had 17α-ethinylestradiol concentrations above the PNEC of 0.1 ng/l (up to 0.17 ng/l). It is worth noting that 17α-ethinylestradiol concentrations were still at least an order of magnitude lower than the sustained 2-5 ng/l concentration found to cause significant ecological disruption in a study lake under Canadian environmental conditions (Kidd et al. 2007) .
To determine the relevance and contribution of the monitored chemicals to the estrogenic activity in the water samples, we compared predicted estrogenicity against measured estrogenicity in the ERα-CALUX bioassay. Predicted estrogenicity was calculated for each sample as the sum of the product of the concentration of each compound (Table 3) and its potency in the ERα-CALUX bioassay (Table 4) . In most cases, measured estrogenicity was in good agreement with predicted estrogenicity, falling within an order of magnitude of the isometric line (i.e., between the parallel dashed lines in Fig. 3) . Leusch et al. (2010) also found good agreement between measured and predicted estrogenic activity in various river, ground, and effluent water samples. Only two of the 53 estrogenic samples (above the upper isometric line) were clearly more biologically active than would be expected from chemical analysis alone, indicating either the presence of estrogenic chemicals below the chemical LOQs or unknown estrogenic compounds. There was also good agreement for most (97 %) of the 232 samples that did not produce significant estrogenicity in the ERα-CALUX bioassay (data not shown), with measured and predicted estrogenicity in agreement at <0.1 ng/l EEQ. Only eight of those samples had predicted activity higher than 0.1 ng/l EEQ (up to 0.25 ng/l EEQ; grey data points in Fig. 3) , with estrone as the only driver of the calculated estrogenicity in all cases. This may indicate the presence of anti-estrogenic compounds in those samples, which would reduce the total estrogenic activity measured in the bioassay.
While there was generally good agreement, predicted estrogenic activity was typically less than the measured activity (in 30 of the 53 estrogenic samples; Fig. 3 ; samples between median line and upper isometric line). Most of those samples (83 %) contained the industrial chemical BPA or 4-t-OP, or both. This hints at the likelihood that other compounds, likely to co-occur with either BPA and/or 4-t-OP, are present in concentrations that make up for the discrepancy between the predicted and the (higher) detected estrogenic activity (Fig. 3) . One credible candidate is 4-nonylphenol (4-NP); 4-t-OP and 4-NP are both long chain alkylphenols, and together with BPA, are used in a variety of industrial operations. 4-NP is also frequently used as a chemical marker for WWTP impacted water and various isomers of 4-NP are often found in conjunction with 4-t-OP (Zhang et al. 2012) . Although 4-NP is a potent estrogenic EAC, it has over 550 possible isomers (Zhang et al. 2012 ) which were not quantified in the present study. Often, technical NP (tNP), a mixture of 20-30 NP isomers, is used as a standard for chemical and biological analysis of water samples (Eganhouse et al. 2009; Preuss et al. 2006 ). However, the biodegradation rate and estrogenic potency of each isomer is dependent on the isomeric composition of the 4-NP molecule, and many isomers are present in impacted freshwater environments (Kim et al. 2005; Routledge and Sumpter 1997) . Therefore, using a tNP or a mono-isomeric standard (such as 4-n-NP) for chemical and biological analysis will not yield accurate results. 4-n-NP was analyzed in the present study but was not detected in any of the samples, probably due to the rare presence of this specific isomer in environmental mixtures. Given the likelihood of 4-NP being present in water extracts containing industrial compounds such as BPA and 4-t-OP, it is probable that a substantial portion of the unaccounted estrogenic activity measured in the 25 samples that contained ether BPA or 4-t-OP, or both, is due to 4-NP.
The discrepancies between predicted and measured endocrine activity confirms previous studies that indicate that only a small fraction of anthropogenic chemicals (and their transformation products) have currently been identified in environmental matrices (Celiz et al. 2009) , and the need for novel approaches to trace chemical analysis, such as the coupling of Assay-specific standards emphasized in bold. Adapted from Leusch et al. 2014a , except for PR-CALUX antagonistic potencies, which were determined in this study, and others as noted.
NA not available, ND not detected, Neg negative in this assay, DHT dihydrotestosterone, EC HPLC with high resolution mass spectrometry (LC-HRMS; Bateman et al. 2009 ) and combinations of nuclear receptorbased affinity columns and LC-HRMS to characterise known and unknown EACs (Jondeau-Cabaton et al. 2013 ).
Progestagenic and anti-progestagenic activities
Progestagenic activity was not detected in any sample (all samples <5 ng/l levonorgestrel equivalent; LevoEQ). However, progestagenic activity was detected recently in Australian WWTP effluents at concentrations up to 5.4 ng/l LevoEQ (LOD=0.01 ng/l LevoEQ; Leusch et al. 2014a) . In a Dutch study, an industrial sample (0.96 ng/l LevoEQ) and surface water sample (1.96 ng/l LevoEQ) had higher progestagenic activity compared to two WWTP effluent samples (0.31-0.38 ng/l LevoEQ) (LevoEQ converted from Org2058 equivalents) (van der Linden et al. 2008) . A more sensitive method may have detected progestagenic activity that was missed with the LOQ of 5 ng/l LevoEQ in the present study. Anti-progestagenic activity (>8 μg/l mifepristone equivalent; MifEQ; Fig 2, bottom) was detected in 16 % (45) of the samples. It was detected in more samples from industrial areas (50 %) than other land uses, such as residential (23 %), downstream of WWTPs (13 %), agricultural (6 %) and undeveloped samples (4 %). Anti-progestagenic activity was 32 μg/l MifEQ at one industrial river site. Similar antiprogestagenic activity was measured in Chinese WWTP effluent (29 μg/l MifEQ, measured with a yeast-based bioassay) (Li et al. 2011) . The identity of the anti-progestagenic compound(s) is currently unknown. However, 4-NP and BPA at high concentrations have been shown to significantly inhibit the binding of progesterone to the recombinant human progesterone receptor (Viswanath et al. 2008) . BPA was also weakly antagonistic in the PR-CALUX assay (Table 4) . Many steroid hormones (DHT, estriol, estrone, etiocholanolone, mestranol and testosterone) also showed weak antagonistic properties in the PR-CALUX. However, for every anti-progestagenic sample (>8 μg/l), there was no predicted anti-progestagenic activity, based on known EAC concentrations (Table 3) and their potencies (Table 4 ). The causative anti-progestagenic compound(s) responsible for the measured activity could not be identified.
Since BPA was found in 65 % of samples (Table 3) , further research focusing on its potential anti-progestagenic effects on Australian aquatic species is warranted. Furthermore, BPA, 4-t-OP and 4-NP have been found together in a high percentage of samples from WWTP effluents and freshwater environments across the world, such as Switzerland (Ahel et al. 1994) , China (Wang et al. 2013) , and France (Cladiere et al. 2013) . Therefore, it is probable that some of the antiprogestagenic activity observed in this study is a result of the presence of 4-NP or other alkylphenols we have not identified. Fig. 3 Comparison of estrogenicity (17β-estradiol equivalent, EEQ) measured in vitro using the ERα-CALUX assay versus predicted estrogenicity based on chemical analysis and relative potencies of compounds in the ERα-CALUX assay ( Table 2) . Limit of quantification=0.1 ng/l EEQ. Grey data points were predicted to have estrogenicity, but none was detected Androgenic and anti-androgenic activities Androgenic activity was not detected in any of the samples using the AR-CALUX assay (all <7 ng/l dihydrotestosterone equivalent; DHTEQ), nor was it detected in 45 WWTPs in VIC (Allinson et al. 2008) , or four WWTP effluents in WA (<2.5 ng/l DHTEQ, measured with the AR-CALUX) (Leusch et al. 2014b ). Coleman et al. (2008) measured androgenic activity in primary and tertiary WWTP effluents at up to 8.9 ng/l testosterone equivalents (TEQ) using the yeast androgen screen (YAS) assay, while Leusch et al. (2006b) measured androgenicity in 15 WWTPs located in QLD with a maximum activity of 736 ng/l testosterone equivalents (TEQ) using the androgen receptor binding assay (ARBA). Another Australian study quantified androgenicity up to 2 ng/l DHTEQ using the AR-CALUX (Leusch et al. 2014a) . A Dutch study reported up to 12 ng/l DHTEQ in surface water using the AR-CALUX assay, with the highest concentrations in industrial and hospital wastewater (up to 86 ng/l DHTEQ) and only modest concentrations in WWTP effluents (up to 0.8 ng/l DHTEQ) (van der Linden et al. 2008 ).
Anti-androgenic activity was only quantifiable in a few (2 %) samples (>60 μg/l flutamide equivalent; FluEQ). Four residential and three industrial samples had anti-androgenic activity ranging from 70 to 257 μg/l FluEQ (data not shown). This was lower than the 370-4,700 μg/l FluEQ reported in an Italian river (YAS; Urbatzka et al. 2007) . Predicted antiandrogenic activity based on known potencies (Table 4) and EAC concentrations (Table 3) did not correlate with measured activity, indicating the presence of unknown anti-androgenic EACs. Estrone is a strong anti-androgen in the AR-CALUX, 15× more potent than flutamide (Table 3) , but with a maximum measured concentration of 57 ng/l (Table 3) , the antiandrogenic activity due to estrone would still only amount to 0.9 μg/l FluEQ (well below the LOQ of 60 μg/l FluEQ). This also applies to BPA and 4-t-OP. Regardless, their detections most likely indicate the presence of other industrial compounds that may have more potent anti-androgenic properties. A variety of environmental contaminants have antiandrogenic activity, such as pesticides (vinclozolin, linuron, prochloraz) , personal care products and pharmaceuticals (flutamide, cyproterone acetate) and industrial compounds (Hotchkiss et al. 2008) . Rostowski et al. (2011) recently identified a range of anti-androgenic compounds in bile of fish exposed to wastewater effluents, including the antibacterial personal care products chlorophene and triclosan, as well as 4-nonylphenol and BPA.
Of the seven anti-androgenic samples, six were also antiprogestagenic (Fig. 4) . The presence of BPA in each of these samples (62-1,820 ng/l) could again indicate the presence of other unknown industrial compounds with endocrine activity, accounting for the remaining anti-androgenic and antiprogestagenic activity.
Samples with multiple endocrine activities
In total, 79 samples produced a biological response in one or more of the six endpoints measured (ERα+, ERα−, AR+, AR −, PR + and PR−). The majority of those samples (55 out of 79) produced a biological response in only one endpoint. Twenty-two samples produced a response in two in vitro assays, and two samples produced activity in three different assays (Fig. 4) . It is well known that certain EACs can affect multiple endocrine functions (e.g., BPA; Table 3 ). Therefore, it is possible that unidentified EACs having multiple endocrine effects are present, for example in some of the 17 samples that were both estrogenic and anti-progestagenic.
Conclusions
Eighty-eight percent of surface water samples contained at least one of the 14 EACs monitored. While EACs were detected in most water samples, their concentrations were usually below typical levels of concern. Only three compounds were measured above PNEC values: BPA and estrone (24 times each) and 17α-ethinylestradiol (seven times), indicating a potential risk to the aquatic environment. Using in vitro bioassays, endocrine activity was detected in 28 % of samples. Nineteen percent of samples had estrogenic activity >0.1 ng/l EEQ (seven samples exceeding the in vitro PNEC of 1 ng/l EEQ), and more than half of those had detectable concentrations of 17α-ethinylestradiol (0.05-0.17 ng/l). Surprisingly, there was no clear association between land-use and 17α-ethinylestradiol concentration suggesting either leaking septic tanks, sewage overflow or lowlevel but widespread wastewater contamination. Antiprogestagenic activity was detected in 16 % of all samples; Fig. 4 Venn diagrams depicting the number of samples with quantifiable endocrine activity of various types. ERα-CALUX limit of quantification (LOQ)=0.1 ng/l 17β-estradiol equivalent (EEQ). Anti-AR-CALUX LOQ=60 μg/l flutamide equivalent (FluEQ). Anti-PR-CALUX LOQ= 8 μg/l mifepristone equivalent (MifEQ). Anti-estrogenic, progestagenic and androgenic activities were not detected in any samples (LOQ=5 μg/l tamoxifen equivalent, TMXEQ; 0.5 ng/l levonorgestrel equivalent, LevoEQ; and 7 ng/l dihydrotestosterone equivalent, DHTEQ; respectively) however, the causative compounds were not identified and require investigation. Very little information exists on the toxicology of the monitored EACs to Australian native species, but based on the available PNECs it is clear that while the risk is low for most compounds, endocrine disruption may occur intermittently at a small number of sites in Australian rivers.
